variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
F11-E135X,F11,"Causes factor XI deficiency in a recessive manner, with symptoms of increased susceptibility to bruising, bleeding, and nosebleeds. This variant appears to be a well-established cause of the disease and is common in patients with Ashkenazi Jewish ancestry. Asakai et al 1991 (PMID: 2052060) reports that about half of pathogenic variants found in patients with Ashkenazi Jewish ancestry are this variant, and the frequency of the variant is high in this ancestry (1 in 8 to 1 in 10 believed to be a carrier of this or another pathogenic variant).",Moderate,Likely,Pathogenic,0.00056,Other,Recessive,Heterozygous,,,5,chr4,187195347,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MYO1A-G662E,MYO1A,"Although one report speculated that this variant may cause dominant, early-onset sensorineural hearing loss, the findings lacked statistical significance. Notably, this gene is not a clinically tested gene and another of the eight variants reported by these authors (S797F) has since been observed in a PGP participant with no symptoms of hearing loss.",Moderate,Uncertain,Pathogenic,0.026,Hearing and vision;Nervous system,Dominant,Heterozygous,12736868,rs33962952,5,chr12,57431402,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MATN3-T303M,MATN3,"An Iceland study implicated this in causing increased osteoarthritis -- in particular, hand osteoarthritis. Because the variant is rare, the statistical significance of observations is weak. The authors estimate that individuals heterozygous for this variant have a 2.1-fold risk for hand osteoarthritis.",Moderate,Uncertain,Pathogenic,0.011,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,12736871,rs77245812,3,chr2,20202930,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
NPC2-V30M,NPC2,"Reported to cause seizures and epilepsy in a recessive manner, as recorded in ClinVar by the Developmental Genetics Unit; King Faisal Specialist Hospital and Research Center. This assertion cites a supporting publication, Alazami et al 2015 (PMID: 25558065), which cite this as a mutation discovered through whole exome sequencing in a study of 143 consanguineous families with neurogenetic diagnoses. Other mutations in this gene are known to cause Neiman-Pick syndrome type C2 (a very rare variant), but neither of the affected siblings in the affected family had typical Neiman-Pick symptoms (progressive neurodegeneration or hepatosplenomegaly).",Moderate,Uncertain,Pathogenic,,Nervous system,Recessive,Heterozygous,,,4,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Heterozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MEFV-R408Q,MEFV,"This variant is associated with Familial Mediterranean Fever, it has generally been reported in cis with other variants. Sugiura et al. conclude that this variant may be weakly involved with the disease.",Low,Uncertain,Pathogenic,0.005,Immune system,Recessive,Heterozygous,10364520;18097735,rs11466024,0,chr16,3299468,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MEFV-P369S,MEFV,"Weak evidence associating this with familial mediterranean fever, but there is a fairly high frequency of this allele. This variant might cause increased susceptibility to the disease but there is not enough evidence to be significant.",Low,Uncertain,Pathogenic,0.0051,Immune system,Recessive,Heterozygous,10090880;18097735,rs11466023,2,chr16,3299586,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
CCR5-S185Shift,CCR5,"Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.",Low,Well-established,Protective,0.048,Immune system,Recessive,Heterozygous,8751444;8791590;8898752,rs333,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
SLC45A2-E272K,SLC45A2,Pigmentation allele for black hair in Caucasian population.,Low,Likely,Benign,0.029,Other,Unknown,Heterozygous,15714523,rs26722,,chr5,33963870,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
ERCC2-L461V,ERCC2,"Reported to cause Xeroderma Pigmentosum (XP) and Photosensitive Trichothiodystrophy (TTD) in a recessive manner. These effects are recorded in ClinVar by OMIM and come, respectively, from Frederick et al 1994 (PMID: 7849702), and Takayama et al 1996 & Takayama et al 1997 (PMID: 8571952 & PMID: 9195225). Notably, the latter papers implicated this variant only in combination with a 15 amino acid deletion on the same chromosome (expected to have a more severe effect – so this variant may have been coincidental and not causal). In ExAC data this variant has an allele frequency of 0.7% in South Asian ancestry, which means at least 1 in 20,000 with South Asian ancestry are expected to be homozygous. In contrast, XP and TTD are both much rarer, with incidences of 1 inn 250,000 to 1,000,000. This information, combined with a lack of more recent confirming literature, indicates the reported effects should probably be considered disproven.",Low,Likely,Benign,0.00028,Skin,Unknown,Heterozygous,,,,chr19,45860626,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
COL6A3-D2831H,COL6A3,"Probably benign, reported by Pan et al. as a presumed-nonpathogenic variant in the gene.",Low,Likely,Benign,0.068,Other,Unknown,Heterozygous,9536084;15563506,rs36104025,,chr2,238247734,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
KEL-T193M,KEL,This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.,Low,Uncertain,Benign,0.032,Blood,Dominant,Heterozygous,7849312,rs8176058,,chr7,142655008,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Homozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
GALT-N314D,GALT,"This variant has an allele frequency of ~8% and is ancestral to ""Duarte"" / ""Duarte 2"" and ""Duarte 1""/""Los Angeles"" galactosemia variants. This variant is evolutionarily ancestral, and in vitro studies fail to support an impact of this variant on enzyme activity. Carney et al. instead implicate a 4 base deletion on the 5' of the GALT gene as being causal and linked to this variant. Galactosemia is typically screened and detected in infants and causes early, severe but nonspecific symptoms (digestive problems, lethargy, failure to thrive).",Low,Uncertain,Benign,0.072,"Mouth, liver, and digestive",Unknown,Heterozygous,10408771;11261429;19224951,rs2070074,,chr9,34649442,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
RXFP2-T222P,RXFP2,"Reported to cause cryptorchidism, as recorded in ClinVar by OMIM (http://www.ncbi.nlm.nih.gov/clinvar/RCV000004376/). This assertion comes from Gorlov et al 2002 (PMID: 12217959) and Ferlin et al 2003 (PMID: 12970298). Gorlov et al found this variant in 1 of 61 patients and, according to OMIM, Ferlin et al found the variant in 4 of 87 patients. ExAC data reports this variant has an allele frequency of 0.7% in Europeans, and Ferlin et al's finding has weak significance for enrichment relative to this allele frequency (p = 0.037). Although cryptorchidism is common, so is this variant – 1 in 70 Europeans are carriers: if it had this effect with high penetrance we would see highly significant enrichment in patients. Although the variant could potentially be a risk factor there is no strong evidence for making this assertion, and the hypothesized effect recorded in ClinVar (i.e. high penetrance) should be considered disproven.",Low,Uncertain,Benign,,Other,Unknown,Heterozygous,,,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
SDHD-H50R,SDHD,"Probably benign. Other mutations in this gene are implicated in causing hereditary paraganglioma or pheochromocytoma syndromes, but this variant is also found in unaffected controls and is considered a nonpathogenic polymorphism by most authors that have reported it.",Low,Uncertain,Benign,0.0066,Cancer,Unknown,Heterozygous,12111639;12386824;17639058;18678321,rs11214077,,chr11,111958677,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Heterozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
ELN-G581R,ELN,"Probably a benign SNP, not rare (4.8% allele frequency in GET-Evidence data).",Low,Uncertain,Benign,0.073,Other,Unknown,Heterozygous,,rs17855988,,chr7,73474825,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
BRCA1-Q356R,BRCA1,"One common variant associated this variant with an increased risk of breast cancer, but a more recent, larger study found no association.",Low,Uncertain,Benign,0.046,Cancer,Unknown,Heterozygous,17341484;19661094,rs1799950,,chr17,41246481,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
RAPSN-R58C,RAPSN,Reported as non-pathogenic polymorphism. ,Low,Uncertain,Benign,0.078,Other,Unknown,Heterozygous,11791205,rs34312154,,chr11,47470345,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0897f1394abcbeb65dfda48ef579e09c2f59bd6d
